News Releases
January 6, 2022
Synlogic Announces Progress Toward 2022 Clinical Milestones and Participation at Upcoming Investor Conferences
November 22, 2021
Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618
November 10, 2021
Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting
November 9, 2021
Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria
November 2, 2021
Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking Conference
October 28, 2021
Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria
October 15, 2021
Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021
October 12, 2021
Synlogic Announces Nature Publication Demonstrating Novel Application of Synthetic Biotic Platform
Displaying 61 - 72 of 225